Scalper1 News
Specialty drugmaker Horizon Pharma’s (HZNP) battered stock rose sharply Friday as the company issued a statement countering its takeover target Depomed ‘s (DEPO) charges regarding its drug-pricing policy. Horizon has been in hot water since Monday, when both it and Valeant Pharmaceuticals (VRX) were the subject of a New York Times article saying the companies were using specialty pharmacies as a way to avoid the efforts of such major Scalper1 News
Scalper1 News